Verification of drug license & valid prescription is strongly advised for the users before dealing in medicines

200 mg Cefixime Dispersible Tablet

₹ 109/Box

Strength200 mg
Dosage FormTablet
CompositionCefixime Dispersible
Pack Size10x10 Tablets
Shelf Life24 Months
Manfactured ByMedalvin Drugs
Pack TypeBox
UseUsed to treat a wide range of bacterial infections
AvailabilityIn Stock

Cefixime 200 mg Dispersible Tablet** is a **broad-spectrum third-generation cephalosporin antibiotic** used to treat a variety of bacterial infections. Its dispersible formulation makes it **easy to swallow**, especially for children or patients with difficulty swallowing tablets.

Find products similar to 200 Mg Cefixime Dispersible Tablet

Find related categories

Shipping Information

PriceExcluding all taxes
Ships fromAmbala
ShippingAs per delivery location

Product Image

200 mg Cefixime Dispersible Tablet-1200 mg Cefixime Dispersible Tablet-2200 mg Cefixime Dispersible Tablet-3

Interested in this product?Get Latest Price from the seller

About the Company

GST Registration Date
16-05-2023
Legal Status of Firm
Limited Company
Nature of Business
Trader - Wholesaler/Distributor
Annual Turnover
0 - 40 L
IndiaMART Member Since
May 2022
GST
06AAQCM6720N1ZW

Medalvin Drugs Private Limited is committed to delivering a comprehensive range of high-quality pharmaceutical products designed to meet diverse healthcare needs. Our product portfolio includes a wide selection of pharmaceutical syrups, tablets, capsules, injections, and topical creams, each formulated with precision and adherence to the highest safety standards. We also offer nutritious protein powders to support overall wellness and recovery.

With a strong focus on quality, innovation, and customer satisfaction, we ensure that every product is manufactured using advanced technology and premium-grade ingredients. Our efficient supply chain and dedicated team enable us to provide effective, reliable, and timely delivery, making us a trusted partner for healthcare professionals, distributors, and patients alike.